MindRank, a clinical-stage artificial intelligence (AI)-empowered drug discovery company, today announced that the first ...
MARQUETTE, MI, UNITED STATES, March 2, 2026 /EINPresswire.com/ -- EXALTA Group (EXALTA) today announced a major ...
MindRank doses first patient in phase III clinical trial of AI-designed oral GLP-1 receptor agonist, MDR-001: Shanghai Saturday, February 28, 2026, 18:00 Hrs [IST] MindRank, a cli ...
Security teams are rarely short of technology. What they lack is capacity. Time to investigate properly. Headroom to think ...
ORLANDO, FL, UNITED STATES, January 27, 2026 /EINPresswire.com/ -- Orakle LLC is pleased to announce the launch of a ...
With MDR certification secured and our expanded IV/CD portfolio now available in Europe, we are taking another ...
SMSR & Sharda University set up Centre for Drug Quantification and Therapeutic Drug Monitoring to strengthen MDR-TB care: Our Bureau, Bengaluru Thursday, February 19, 2026, 14:45 ...
A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.
Developed through a multi‑year collaboration with IHU Strasbourg, mAI Companion® has received MDR CE Mark certification, becoming the first‑of‑its‑kind AI assistant for pancreatic EUS approved for ...
The presentations include late-breaking clinical data, oral sessions and posters highlighting real-world outcomes, cardiac energetics, hospitalization impact, left ventricular ejection fraction (LVEF) ...
Nexstim’s NBS 6 system receives MDR certification in the EU for use in Post-Operative Rehabilitation
With the certification received, Nexstim is allowed to start marketing and selling the NBS 6 system within the European Union for the treatment of surgically induced new or worsening post-operative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results